TrialCirculation2018

Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).

Robert P Giugliano et al.PubMed ↗Publisher ↗

No numbers read from the abstract.